Longitudinal change in FEV1 in adults with cystic fibrosis treated with elexacaftor–tezacaftor–ivacaftor in France: a prospective observational study

The Lancet Respiratory Medicine · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles